Philips NV

PHIA

NL0000009538

Advanced Medical Equipment & Technology

Market Closed - Euronext Amsterdam Other stock markets 11:35:15 2024-06-28 EDT			5-day change	1st Jan Change
23.59 ^EUR	-1.30%		-3.83%	+15.70%

06-28	PHILIPS NV : JP Morgan reiterates its Neutral rating	ZD
06-27	Chinese-owned chipmaker Nexperia invests $200 mln in European expansion	RE

PHILIPS NV : Gets a Sell rating from Deutsche Bank

January 15, 2024 at 08:29 am

Deutsche Bank analyst reiterate his Sell rating on the stock. The target price is revised upwards from EUR 17 to EUR 15.

Latest news about Philips NV

PHILIPS NV : JP Morgan reiterates its Neutral rating	06-28	ZD
Chinese-owned chipmaker Nexperia invests $200 mln in European expansion	06-27	RE
Chinese-owned chipmaker Nexperia invests $200 mln in European expansion	06-27	RE
Royal Philips' Largest Shareholder Exor Increases Stake to 17.51%	06-26	MT
Philips: holding company Exor increases its stake	06-26	CF
Philips shares up 2.5% after Agnelli family-owned Exor increases stake	06-26	RE
European Equities Traded in the US as American Depositary Receipts Nudge Higher Tuesday Trading	06-25	MT
PHILIPS NV : UBS reiterates its Neutral rating	06-25	ZD
European Equities Traded in the US as American Depositary Receipts Move Higher in Thursday Trading	06-20	MT
Philips: cancellation of almost 4.4 million shares	06-19	CF
Royal Philips Receives FDA 510(K) Clearance for Zenition 90 Motorized Mobile C-Arm	06-17	MT
Royal Philips Zenition 90 Motorized Receives FDA 510(k) clearance, helping clinicians deliver high quality care with a high-powered and fast motorized mobile C-arm	06-17	CI
Royal Philips Introduces Duo Venous Stent System for Symptomatic Venous Outflow Obstruction	06-12	MT
Philips Launches Duo Venous Stent System for Treatment of Symptomatic Venous Outflow Obstruction	06-12	CI
PHILIPS NV : Goldman Sachs keeps its Buy rating	06-07	ZD
Royal Philips Introduces AI-Powered Cardiovascular Ultrasound Platform	06-04	MT
Philips: refinancing for 700 million euros	05-24	CF
Royal Philips Prices EUR700 Million of Notes due 2032	05-24	MT
Philips Prices 700 Million Euros Fixed Rate Notes Offering	05-23	MT
Royal Philips Launches Ambulatory Cardiac Monitoring Service in Spain	05-22	MT
Royal Philips Rolls Out Ambulatory Cardiac Monitoring Tools in Spain	05-22	MT
European Equities Traded in the US as American Depositary Receipts Start Week Marginally Higher in Monday Trading	05-20	MT
European Equities Traded in the US as American Depositary Receipts Trend Modestly Higher in Friday Trading	05-17	MT
Koninklijke Philips N.V. (Royal Philips) to Issue 30.86 Million New Shares After Setting Dividend Exchange Ratio for 2023	05-15	MT
European Equities Traded in the US as American Depositary Receipts Rise in Thursday Trading	05-09	MT

Koninklijke Philips N.V. is a leading health technology company focused on improving people's health and enabling better outcomes across the health continuum from healthy living and prevention, to diagnosis, treatment and home care. The group leverages advanced technology and deep clinical and consumer insights to deliver integrated solutions. Koninklijke Philips N.V. is a leader in diagnostic imaging, image-guided therapy, patient monitoring and health informatics, as well as in consumer health and home care.

Sector

Advanced Medical Equipment & Technology

Calendar

2024-07-29 - Q2 2024 Earnings Release

Related indices

STOXX EUROPE 600 (EUR) , AEX

More about the company

Income Statement Evolution

More financial data

Analysis / Opinion

ROYAL PHILIPS : The Dutch giant now poised for much better times

April 29, 2024 at 01:48 pm

Philips NV : The sleep apnea case makes a brutal comeback

October 06, 2023 at 05:20 am

Product recalls, renewed growth, investment in AI. Roy Jakobs, Philips CEO

September 29, 2023 at 10:33 am

More Strategies

Ratings for Philips NV

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

HOLD

Number of Analysts

Last Close Price

23.59 EUR

Average target price

25.46 EUR

Spread / Average Target

+7.92%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Advanced Medical Equipment & Technology

	1st Jan change	Capi.
PHILIPS NV	+15.70%	23.58B
DANAHER CORPORATION	+8.00%	185B
INTUITIVE SURGICAL, INC.	+31.86%	158B
BOSTON SCIENTIFIC CORPORATION	+33.21%	113B
SIEMENS HEALTHINEERS AG	+2.28%	64.32B
EDWARDS LIFESCIENCES CORPORATION	+21.14%	55.66B
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.	+0.11%	48.41B
AGILENT TECHNOLOGIES, INC.	-6.76%	37.82B
GE HEALTHCARE TECHNOLOGIES INC.	+0.78%	35.57B
RESMED, INC.	+11.28%	28.12B

Other Advanced Medical Equipment & Technology

Philips NV

Equities

PHIA

NL0000009538

Advanced Medical Equipment & Technology

PHILIPS NV : Gets a Sell rating from Deutsche Bank

Latest news about Philips NV

Chart Philips NV

Company Profile

Income Statement Evolution

Analysis / Opinion

Ratings for Philips NV

Analysts' Consensus

EPS Revisions

Quarterly earnings - Rate of surprise

Sector Other Advanced Medical Equipment & Technology